he 2026 EU GMP Annex 1 Update Means for Veterinary Product Supplier Qualification The 2026 EU GMP Annex 1 changes mark a major regulatory shift, introducing a full separation between human and veterinary manufacturing requirements. […]

Rx-360 is committed to supporting the global pharmaceutical industry in meeting regulatory standards worldwide. In response to the National Medical Products Administration (NMPA) release of Appendices One and Two of Article 310 of the Good […]